VORTIOXETINE HYDROBROMIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Vortioxetine Hydrobromide, and what generic alternatives are available?
Vortioxetine Hydrobromide is a drug marketed by Zydus Pharms and is included in one NDA.
The generic ingredient in VORTIOXETINE HYDROBROMIDE is vortioxetine hydrobromide. There are sixteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the vortioxetine hydrobromide profile page.
Paragraph IV (Patent) Challenges for VORTIOXETINE HYDROBROMIDE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
TRINTELLIX | Tablets | vortioxetine hydrobromide | 5 mg, 10 mg, 15 mg and 20 mg | 204447 | 15 | 2017-10-02 |
US Patents and Regulatory Information for VORTIOXETINE HYDROBROMIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zydus Pharms | VORTIOXETINE HYDROBROMIDE | vortioxetine hydrobromide | TABLET;ORAL | 211146-001 | Sep 17, 2021 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Zydus Pharms | VORTIOXETINE HYDROBROMIDE | vortioxetine hydrobromide | TABLET;ORAL | 211146-002 | Sep 17, 2021 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Zydus Pharms | VORTIOXETINE HYDROBROMIDE | vortioxetine hydrobromide | TABLET;ORAL | 211146-003 | Sep 17, 2021 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |